ImmunoBrain Checkpoint
Research - Ness Ziona, Center District, Israel
ImmunoBrain Checkpoint Employees
ImmunoBrain Checkpoint Senior Management
ImmunoBrain Checkpoint Details
ImmunoBrain Checkpoint (IBC) is a biopharmaceutical company transforming the fight against neurodegeneration and aging by targeting the immune system, restoring brain immune communications and boosting natural repair mechanisms. IBC's lead program is a proprietary antibody targeting the inhibitory immune checkpoint pathway, PD-1/PD-L1, to treat Alzheimer's disease. IBC's novel approach for the treatment of neurodegeneration is based on years of innovative, cutting-edge scientific discoveries made in the lab of Prof. Michal Schwartz at the Weizmann Institute of Science.
ImmunoBrain Checkpoint Technologies
Email Providers
Gmail
CMS
WP Engine
Tag Management
Google Tag Manager
Other
Google Apps
Hosting
Google Cloud Hosting
Online Video Platforms
Vimeo